Dr. Osnat Levtzion-Korach gives an update on the situation at Shamir Medical Center.
Shamir Medical Center – Update from Director General
Breaking News
Breaking News
Breaking News
Dr. Osnat Levtzion-Korach gives an update on the situation at Shamir Medical Center.
Because of the missile attacks from Iran, the Hadassah Hospital in Jerusalem, like other hospitals in the country, has been forced to find a solution to be able to continue attending to patients in times of war.
Regrettably, with a long experience of many years, the enemy does not make a difference between civil and military objectives, so hospitals, the centers that provide medical assistance to the population, have had to find solutions to the threats and the danger.
Hadassah Ein Kerem Hospital, in its modern new Davidson’s Tower from a few years ago, was already designed for this war scenario, and some of its operating rooms were installed on the underground floors.
In the actual conflict, an in-patient department for patients who could not be moved independently in an emergency was added to one of the underground parking lots.
This series of photographs provides a perspective of the home front, an intimate look at the medical reality beneath the surface: the civilian experience in a subterranean wartime environment.
A unique place with unique people in a unique hospital of a unique country.
CLICK HERE TO READ THE ORIGINAL ARTICLE
Hadassah researcher Prof Eitan Kerem. He hopes the drug will be able to treat other diseases caused by the nonsense mutation.Seminal research led by an Israeli team from Hadassah Hospital in Jerusalem may yield dramatic relief for cystic fibrosis (CF) patients in the next few years. It also opens up new opportunities and hope for treating genetic diseases such as muscular dystrophy.
The promising new oral drug, PTC124, is being developed by US biopharmaceutical company PTC Therapeutics, located in New Jersey, in conjunction with Hadassah’s researchers Prof. Eitan Kerem and Dr. Michael Wilschanski. It has already passed a milestone in drug development.
This month, the researchers announced positive results from their Phase II clinical trials in humans, and published their findings in the prestigious medical journal The Lancet. The orally administered pill helped 16 out of 23 Israeli study patients improve their chloride (salt) channel functioning.
A treatment for other diseases
“We hope the drug will be able to treat other diseases caused by the mechanism responsible for this mutation,” says Kerem, head of pediatrics at Hadassah University Medical Center on Jerusalem’s Mount Scopus.
This year, the Jerusalem Film Festival acknowledged not only achievements in cinema but also courage in advocating on behalf of Israel.
Standing before a live audience of 7,000 film industry leaders and dignitaries on July 17, Israeli-born international movie star Gal Gadot proudly accepted Hadassah’s Power of Dreams Award, which praises the actress for “using [her] global platform to advocate for truth and justice.”
“This is an opportunity for me to say a huge thank-you for the award to Hadassah, The Women’s Zionist Organization of America, which plays a vital role in the development of medicine in Israel,” Gadot said.
“The decision to honor Gal Gadot was a natural one,” said Hadassah National President Carol Ann Schwartz, who presented the award to Gadot with Hadassah Medical Organization Board Chair Dalia Itzik. “At a time when Israel faces complex and painful challenges, her voice offers clarity and strength. This award is not just about dreams fulfilled. It is about the responsibility that comes with influence and the hope it will continue to inspire,” Schwartz said.
Gadot is the second person to receive Hadassah’s Power of Dreams Award, following actress and entrepreneur Gwyneth Paltrow, who received the award in 2016.
